Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer

Background Adjuvant endocrine therapy (AET) is prescribed to women for 5–10 years after treatment for estrogen receptor positive (ER+ve), early-stage breast cancer. AET has proven effectiveness in reducing the risk of recurrence of breast cancer and mortality. However, adherence is known to be suboptimal with around 20% discontinuing by 2 years and up to 50% discontinuing by 5 years. Interventions are needed to support women taking AET after breast cancer. The aim of this study was to develop and pilot test an e-health app for this population. Methods Two focus groups (n=15) and five interviews were conducted with women following treatment for early-stage breast cancer to assess the likely acceptability of an e-health app and to inform the content (Phase I). Following development of a prototype e-health app, a simple heuristic usability test was completed by five women in order to identify any design usability problems (Phase II). A further 18 women used the app for 1 month between July and August 2016, after which they were interviewed by telephone to collect their experiences and views of the app (Phase III). Results The prototype e-health app included evidence-based information on effectiveness of AET, an electronic side-effects diary, a peer support forum, a repeat prescription reminder, suggested strategies for facilitating adherence and managing any side effects that occur, and a link to further evidence and useful organizations for further information and support. The app was received positively by women. Women found the app useful as it emphasized the importance of taking AET, helped them manage their side effects and provided details of support organizations, while offering empathy and exchange of suggestions for self-management strategies through the peer support forum. Conclusion Overall, findings suggest that this novel e-health app has potential as a feasible medium for promoting adherence to AET. Future research should evaluate the efficacy of the app in supporting women and promoting adherence.

[1]  F. Walter,et al.  Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence , 2018, Patient preference and adherence.

[2]  Lucy Yardley,et al.  Understanding acceptability of and engagement with Web‐based interventions aiming to improve quality of life in cancer survivors: A synthesis of current research , 2018, Psycho-oncology.

[3]  Dawn L. Hershman,et al.  Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer , 2011, Breast Cancer Research and Treatment.

[4]  Enrico Coiera,et al.  An e‐health strategy to facilitate care of breast cancer survivors: A pilot study , 2016, Asia-Pacific journal of clinical oncology.

[5]  Peter R. Harris,et al.  A user-centred approach to developing bWell, a mobile app for arm and shoulder exercises after breast cancer treatment , 2017, Journal of Cancer Survivorship.

[6]  K. Bennett,et al.  Women’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour , 2015, Supportive Care in Cancer.

[7]  M. Hancock Appraisal of Clinical Practice Guideline: Early and locally advanced breast cancer: diagnosis and management. NICE guideline [NG101]. , 2019, Journal of physiotherapy.

[8]  Lyndsay D. Hughes,et al.  Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review , 2017, Patient preference and adherence.

[9]  J. Thigpen Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen , 2010 .

[10]  Ara Darzi,et al.  Smartphone breast applications - what's the evidence? , 2014, Breast.

[11]  S. Michie,et al.  Using the Internet to Promote Health Behavior Change: A Systematic Review and Meta-analysis of the Impact of Theoretical Basis, Use of Behavior Change Techniques, and Mode of Delivery on Efficacy , 2010, Journal of medical Internet research.

[12]  S. Chan,et al.  A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial , 2017, BMC Cancer.

[13]  A. Coulter,et al.  European patients' views on the responsiveness of health systems and healthcare providers. , 2005, European journal of public health.

[14]  A. Giobbie-Hurder,et al.  Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Thompson,et al.  A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer , 2014, BMJ Open.

[16]  Malgorzata Roos,et al.  A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial , 2016, Journal of medical Internet research.

[17]  A M Thompson,et al.  Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer , 2008, British Journal of Cancer.

[18]  Mario Lozano-Lozano,et al.  Integral strategy to supportive care in breast cancer survivors through occupational therapy and a m-health system: design of a randomized clinical trial , 2016, BMC Medical Informatics and Decision Making.

[19]  Guido Giunti,et al.  A biopsy of Breast Cancer mobile applications: state of the practice review , 2018, Int. J. Medical Informatics.

[20]  F. Walter,et al.  Factors associated with intentional and unintentional non‐adherence to adjuvant endocrine therapy following breast cancer , 2018, European journal of cancer care.

[21]  Lindsey E. Dayer,et al.  Smartphone medication adherence apps: potential benefits to patients and providers. , 2013, Journal of the American Pharmacists Association : JAPhA.

[22]  Virginia G Kaklamani,et al.  Adjuvant Chemotherapy Guided by a 21‐Gene Expression Assay in Breast Cancer , 2018, The New England journal of medicine.

[23]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[24]  Karen Waltorp Smartphone , 2020, Why Muslim Women and Smartphones.

[25]  P. Donnan,et al.  Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality , 2013, British Journal of Cancer.

[26]  J. L. Bender,et al.  A Lot of Action, But Not in the Right Direction: Systematic Review and Content Analysis of Smartphone Applications for the Prevention, Detection, and Management of Cancer , 2013, Journal of medical Internet research.

[27]  K. Bennett,et al.  A nested case–control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I–III breast cancer , 2013, British Journal of Cancer.

[28]  Jakob Nielsen,et al.  Heuristic Evaluation of Prototypes (individual) , 2022 .

[29]  Judith H Hibbard,et al.  How engaged are consumers in their health and health care, and why does it matter? , 2008, Research brief.

[30]  K. Farris,et al.  Mobile Applications to Improve Medication Adherence. , 2017, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[31]  D. Bowen,et al.  Pilot and Feasibility Test of a Mobile Health-Supported Behavioral Counseling Intervention for Weight Management Among Breast Cancer Survivors , 2016, JMIR cancer.

[32]  Wanda Pratt,et al.  Healthcare in the pocket: Mapping the space of mobile-phone health interventions , 2012, J. Biomed. Informatics.

[33]  Ilse de Bourdeaudhuij,et al.  Design and process evaluation of an informative website tailored to breast cancer survivors’ and intimate partners’ post-treatment care needs , 2012, BMC Research Notes.

[34]  W. Chou,et al.  Health-related Internet use among cancer survivors: data from the Health Information National Trends Survey, 2003–2008 , 2011, Journal of cancer survivorship : research and practice.

[35]  C. Yuan,et al.  Self-management programme for cancer patients: a literature review. , 2011, International nursing review.

[36]  A. Christensen,et al.  Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research , 2014, Journal of Cancer Survivorship.